• Video Abstract: Pros and Cons of Continued Aspirin Use in Patients with Lower GI Bleeding

Video Abstract: Pros and Cons of Continued Aspirin Use in Patients with Lower GI Bleeding

In aspirin users with a history of lower gastrointestinal bleeding, continued aspirin use increases risk of recurrent bleeding by almost 3-fold, but reduces risk of serious cardiovascular events by 40% and risk of death from other causes by 17%, researchers report in the August issue of Gastroenterology. First author Francis K.L. Chan discusses the group’s

Read more
  • Do NSAIDs Prevent PEP?

Do NSAIDs Prevent PEP?

Rectal indomethacin does not prevent pancreatitis following endoscopic retrograde cholangiopancreatography (ERCP), researchers report from a randomized controlled study published in the April issue of Gastroenterology. These findings contradict more than a decade of evidence that nonsteroidal anti-inflammatory drugs (NSAIDs) decrease the risk of post-ERCP pancreatitis (PEP). Acute pancreatitis is the

Read more
  • Can a Cocktail Prevent Colorectal Adenoma Recurrence?

Can a Cocktail Prevent Colorectal Adenoma Recurrence?

The combination of calcitriol, aspirin, and calcium carbonate did not prevent recurrence of colorectal adenomas over a 3-year period, found a prospective study published in the January issue of Gastroenterology. This negative result might have been affected by the numbers of smokers included in the study or low doses of

Read more
  • Expert Panel Recommends Aspirin Therapy for Prevention of Colorectal Cancer

Expert Panel Recommends Aspirin Therapy for Prevention of Colorectal Cancer

For the first time, an expert panel has recommended aspirin therapy to prevent not only heart attacks but also colorectal cancer. The guideline for those at high risk of heart disease, published September 14 in a draft report from the US Preventive Services Task Force is the first time a major

Read more

Video: Does Stress Cause Ulcers?

Psychological stress increases the risk for peptic ulcers, partly by affecting health risk behaviors, researchers report in the March issue of Clinical Gastroenterology and Hepatology. Although peptic ulcers are considered to be caused by stress, Helicobacter pylori and nonsteroidal anti-inflammatory drugs (NSAIDs) took over as the accepted causes. However, less than a third of peptic ulcers develop in people

Read more
  • Do Selective Serotonin Reuptake Inhibitors Increase Risk for GI Bleeding?

Do Selective Serotonin Reuptake Inhibitors Increase Risk for GI Bleeding?

Use of selective serotonin reuptake inhibitors increases risk for upper gastrointestinal bleeding (UGIB) by 55%—and even more among patients also taking nonsteroidal anti-inflammatory or antiplatelet drugs, researchers report in the January issue of Clinical Gastroenterology and Hepatology. Risk might be reduced significantly by concomitant use of acid-suppressing drugs. Selective serotonin

Read more
  • Video: Risk of Upper Gastrointestinal Bleeding From Different Drug Combinations

Video: Risk of Upper Gastrointestinal Bleeding From Different Drug Combinations

Combined use of nonselective nonsteroidal anti-inflammatory drugs (nNSAIDs), COX-2 selective inhibitors, or low-dose aspirin with selective serotonin reuptake inhibitors significantly increases the risk of upper gastrointestinal (GI) bleeding, researchers report in the October issue of Gastroenterology. In their case series analysis of data from 114,835 patients with upper GI bleeding (930,888 person-years of follow-up),

Read more

Are Patients Who Take Continuous NSAIDs Receiving Gastroprotection?

Among patients who continuously take nonsteroidal anti-inflammatory drugs (NSAIDs), a third of co-prescriptions for drugs to prevent gastrointestinal (GI) damage are not renewed within the next 2 years. This discontinuation increases patients’ risk of stomach pain, inflammation, or ulcers, according to the May issue of Clinical Gastroenterology and Hepatology. Patients

Read more

Is it Safe for Patients With Cardiovascular Disease to Discontinue Low-Dose Aspirin Therapy?

In patients with cardiovascular disease, discontinuing low-dose aspirin therapy after peptic ulcer bleeding increases risk of death and acute cardiovascular events almost 7-fold, according to the January issue of Clinical Gastroenterology and Hepatology. Many patients with cardiovascular disease receive low-dose aspirin, for its cardioprotective effects. However, aspirin can also cause

Read more

How Does Aspirin Prevent Cancer?

Aspirin blocks proliferation of colorectal cancer cells and causes them to self destruct by inhibiting the mechanistic target of rapamycin (mTOR), according to the June issue of Gastroenterology. Aspirin is a nonsteroidal anti-inflammatory drug that has been shown in many studies to reduce risk of cancer—particularly of CRC—by unknown mechanisms.

Read more